Daily FNArena News - Australia

ResMed posted strong sales growth in the March quarter but brokers remain preoccupied with the price pressures in the US health care system.

Weekly update on recommendation, target price, and earnings forecast changes.

A wrap of the day’s activity on the Australian stock market.

Analysts have been left scratching their heads as to why an energy company would become a yield play rather than a growth play. The spotlight now turns to BHP and Rio, which like Woodside have deferred spending.

Three of the major banks deliver half year reports over the next few weeks and brokers take a peek at what to expect.

Mobile phones have provided an impetus to online gambling, and wagering operators with a strong online presence stand to benefit.

Analysts are mostly positive on logistics solutions company Royal Wolf, with Moelis the latest broker to chime in with a Buy call.

A wrap of the day’s activity on the Australian stock market.

OZ Minerals’ share price was already under pressure before the company released a March production report which disappointed already pessimistic analysts. But is OZ now a cheap bet?

IMF researchers show how important it is to consider the role of policies in determining the growth outcomes during recoveries.